publication date: Feb. 27, 2015

Hwu Named Cancer Medicine Division Head at MD Anderson

 

PATRICK HWU was named division head of Cancer Medicine at MD Anderson Cancer Center, effective March 4. Hwu joined MD Anderson in 2003 as the first chair of Melanoma Medical Oncology. He is also currently chair of Sarcoma Medical Oncology.

Hwu’s selection came after a national search to fill the position currently being served by Richard Champlin on an interim basis. Champlin will continue to serve as chair of Stem Cell Transplantation and Cellular Therapy.

“[Hwu is] a seasoned leader and has successfully chaired two departments and served as co-director of MD Anderson’s Center for Cancer Immunology Research and its immunotherapy platform,” said Ethan Dmitrovsky, MD Anderson provost and executive vice president. “He has also held endowed positions, including the Sheikh Mohamed Bin Zayed Al Nahyan Distinguished University Chair in Cancer Research.”

Hwu has helped launch the field of gene modified T cells, publishing research on the first chimeric antigen receptor directed against cancer. Clinical trials using CAR-transduced T cells now are being studied in many types of cancers, and MD Anderson has established an adoptive T cell therapy program.

In addition, Hwu has produced a study of combination T cell and dendritic cell therapy and a study of T cells modified with chemokine receptor genes to enhance their migration to the tumor. His most recent preclinical studies have focused on combinations of immune checkpoint blockade and T cell therapy, as well as rational combinations of targeted therapies and immunotherapies.

During Hwu’s 11 years as Melanoma Medical Oncology chair, the department evolved from a purely clinical group to an NIH-funded academic program. The department has grown from … Continue reading 41-08 Hwu Named Cancer Medicine Division Head at MD Anderson

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.